FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3134452930> ?p ?o ?g. }

• W3134452930 abstract "Dear Editor, Disproportionately increased COVID-19 severity in men has resulted in investigation into androgen-regulated transcription of transmembrane protease-serine 2 (TMPRSS2), which mediates SARS-CoV-2 infectivity.1 Several dermatologic disorders are associated with androgen excess, such as polycystic ovarian syndrome (PCOS), acne cystica, and hirsutism in women.2 Considering the implication that androgens play a role in COVID-19 infection-related outcomes in men, we examined COVID-19 incidence and severity in women with these dermatologic conditions. The HIPAA-limited University of California COVID Research Data Set (UC CORDS) provides access to health records for patients tested for COVID-19 across UC medical institutions.3 As of October 8, 2020, it had COVID-19 test results, demographics, hospitalization, and mortality on 117,529 women, age 0–65. Data on diagnoses of acne vulgaris, PCOS, or hirsutism, and concomitant use of spironolactone, estradiol (proxy for oral contraceptive pills), or metformin for at least 30 days were collected. Chi-squared and Fisher's exact tests were used for statistical analysis. The UC CORDS female population had a 4.0% (n = 4,693, age: 0–65, avg age: 35) COVID-19-positive test rate. Of these, 6,195 had acne vulgaris, with a 3.2% (n = 201, age: 0–65, avg age: 33) COVID-19 infection rate, 1,590 women had PCOS, of which 3.1% (n = 49, age: 18–50, avg age: 34) were COVID-19 positive, and 687 had hirsutism, with a 3.6% (n = 25, age: 19–65, avg age: 38) COVID-19-positive rate, none of which were different from women without these conditions (P = 0.002, P = 0.062, P = 0.635, respectively) (Table 1). Analysis of hospitalization rates among COVID-19-positive women (n = 4,693) in the UC CORDS indicated that 11.4% (n = 535, avg age: 41) were hospitalized within 2 weeks (1 week prior or subsequent) of testing. COVID-19-positive women with acne (n = 201) had a 4.5% (n = 9, average age: 38) hospitalization rate (P = 0.002). COVID-19-positive women with PCOS or hirsutism had 6.1% (n = 3, average age 32) and 8.0% (n = 2, average age 40) hospitalization, respectively, which was not significantly different from those without (P = 0.363, P = 1.0, respectively). Lastly, these women did not have significantly different mortality rates compared to those without these conditions (Table 1). Further analysis of the populations on targeted therapies revealed no significant associations in both the COVID-19 infection rates or hospitalization rates of women with acne, PCOS, or hirsutism on spironolactone, estradiol, or metformin (P > 0.05) (Table 2). Our results suggest that there is no evidence for an increased risk of COVID-19 infection, hospitalization, or mortality in women with acne vulgaris, PCOS, or hirsutism. Additionally, management with common medications was not associated with COVID-19 infection risk. In particular, spironolactone, which was speculated early in the pandemic to increase the risk of COVID-19 infection by increasing circulating angiotensin converting enzyme (ACE), did not appear to influence infection risk in our patients. The lower COVID-19 rates of infection and hospitalization among women with acne were possibly related to the younger average age (acne: 33 years vs. non-acne: 35 years). Still, these data are all suggestive, as serum hormone levels were not collected in these women, and thus there is no direct evidence of the impact of androgens. Limitations include the use of a database reflective of tertiary care facilities, low case frequency, and lack of clinical details due to the de-identified database. While androgens likely play a role in COVID-19 outcomes, there are several other sex differences to account for, like varying immune response and the potential protective effect of estrogens/progesterone.4 Results from ongoing trials with TMPRSS2 inhibitors and anti-androgen therapy may elucidate the impact of androgens in both sexes and have a potential role in future COVID-19 management.5 Insight on the role of sex hormones on disease incidence and severity will contribute to better understanding of at-risk populations. The project described was supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant UL1 TR001414. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH." @default.
• W3134452930 created "2021-03-15" @default.
• W3134452930 creator A5005201276 @default.
• W3134452930 creator A5011256255 @default.
• W3134452930 creator A5014428129 @default.
• W3134452930 creator A5018999404 @default.
• W3134452930 creator A5020027481 @default.
• W3134452930 creator A5029005167 @default.
• W3134452930 date "2021-03-02" @default.
• W3134452930 modified "2023-10-17" @default.
• W3134452930 title "Androgens and women: COVID‐19 outcomes in women with acne vulgaris, polycystic ovarian syndrome, and hirsutism" @default.
• W3134452930 cites W2211635736 @default.
• W3134452930 cites W3025990187 @default.
• W3134452930 cites W3046840767 @default.
• W3134452930 cites W3049375179 @default.
• W3134452930 doi "https://doi.org/10.1111/ijd.15473" @default.
• W3134452930 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8014631" @default.
• W3134452930 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33650165" @default.
• W3134452930 hasPublicationYear "2021" @default.
• W3134452930 type Work @default.
• W3134452930 sameAs 3134452930 @default.
• W3134452930 citedByCount "4" @default.
• W3134452930 countsByYear W31344529302021 @default.
• W3134452930 countsByYear W31344529302022 @default.
• W3134452930 countsByYear W31344529302023 @default.
• W3134452930 crossrefType "journal-article" @default.
• W3134452930 hasAuthorship W3134452930A5005201276 @default.
• W3134452930 hasAuthorship W3134452930A5011256255 @default.
• W3134452930 hasAuthorship W3134452930A5014428129 @default.
• W3134452930 hasAuthorship W3134452930A5018999404 @default.
• W3134452930 hasAuthorship W3134452930A5020027481 @default.
• W3134452930 hasAuthorship W3134452930A5029005167 @default.
• W3134452930 hasBestOaLocation W31344529301 @default.
• W3134452930 hasConcept C126322002 @default.
• W3134452930 hasConcept C16005928 @default.
• W3134452930 hasConcept C2776371013 @default.
• W3134452930 hasConcept C2777391703 @default.
• W3134452930 hasConcept C2777673923 @default.
• W3134452930 hasConcept C2780186808 @default.
• W3134452930 hasConcept C2908647359 @default.
• W3134452930 hasConcept C29456083 @default.
• W3134452930 hasConcept C3018442814 @default.
• W3134452930 hasConcept C511355011 @default.
• W3134452930 hasConcept C71924100 @default.
• W3134452930 hasConcept C99454951 @default.
• W3134452930 hasConceptScore W3134452930C126322002 @default.
• W3134452930 hasConceptScore W3134452930C16005928 @default.
• W3134452930 hasConceptScore W3134452930C2776371013 @default.
• W3134452930 hasConceptScore W3134452930C2777391703 @default.
• W3134452930 hasConceptScore W3134452930C2777673923 @default.
• W3134452930 hasConceptScore W3134452930C2780186808 @default.
• W3134452930 hasConceptScore W3134452930C2908647359 @default.
• W3134452930 hasConceptScore W3134452930C29456083 @default.
• W3134452930 hasConceptScore W3134452930C3018442814 @default.
• W3134452930 hasConceptScore W3134452930C511355011 @default.
• W3134452930 hasConceptScore W3134452930C71924100 @default.
• W3134452930 hasConceptScore W3134452930C99454951 @default.
• W3134452930 hasFunder F4320337472 @default.
• W3134452930 hasIssue "7" @default.
• W3134452930 hasLocation W31344529301 @default.
• W3134452930 hasLocation W31344529302 @default.
• W3134452930 hasLocation W31344529303 @default.
• W3134452930 hasLocation W31344529304 @default.
• W3134452930 hasOpenAccess W3134452930 @default.
• W3134452930 hasPrimaryLocation W31344529301 @default.
• W3134452930 hasRelatedWork W1137480890 @default.
• W3134452930 hasRelatedWork W1528170622 @default.
• W3134452930 hasRelatedWork W1819748876 @default.
• W3134452930 hasRelatedWork W2044827656 @default.
• W3134452930 hasRelatedWork W2068018112 @default.
• W3134452930 hasRelatedWork W2069962887 @default.
• W3134452930 hasRelatedWork W2434689181 @default.
• W3134452930 hasRelatedWork W2435742746 @default.
• W3134452930 hasRelatedWork W3134291508 @default.
• W3134452930 hasRelatedWork W2555385213 @default.
• W3134452930 hasVolume "60" @default.
• W3134452930 isParatext "false" @default.
• W3134452930 isRetracted "false" @default.
• W3134452930 magId "3134452930" @default.
• W3134452930 workType "article" @default.